Schedule of anti-dilutive weighted average shares (Details) - shares |
6 Months Ended | |
|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
|
| Notes and other explanatory information [abstract] | ||
| Convertible loan notes – assuming all loan notes are converted to equity | 856,253 | 33,768 |
| 2021 Share Option Scheme | 7,934 | 52,305 |
| Warrants in issue | 7,083,037 | 318,443 |
| Dilutive effect securities | 7,947,224 | 404,516 |
| X | ||||||||||
- Definition Dilutive effect of warrants in issue. No definition available.
|
| X | ||||||||||
- Definition Dilutive effect securities. No definition available.
|
| X | ||||||||||
- Definition The potential dilutive effect on the weighted average number of ordinary shares that relate to the assumed conversion of the entity's convertible instruments. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The potential dilutive effect on the weighted average number of ordinary shares that relate to the assumed exercise of the entity's share options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|